Lumona 4 mg/3.5 gm (Oral Granules)
3.5 gm sachet: ৳ 8.00 (30's pack: ৳ 240.00)
Medicine Details
| Category | Details |
|---|---|
| Generic | Montelukast sodium |
| Company | Eskayef pharmaceuticals ltd |
| Also available as |
Indications
- Prophylaxis and chronic treatment of asthma
- Acute prevention of Exercise-Induced Bronchoconstriction (EIB)
- Relief of symptoms of Allergic Rhinitis (AR): Seasonal & Perennial Allergic Rhinitis
Pharmacology
- Montelukast is a selective and orally active leukotriene receptor antagonist
- Inhibits the cysteinyl leukotriene receptor (CysLT1)
- Correlated with the pathophysiology of asthma & allergic rhinitis
Dosage & Administration
- Adults and adolescents dosage: Montelukast 10 mg tablet once daily
- Pediatric patients dosage: 5 mg tablet once daily (6-14 years), 4 mg tablet once daily (2-5 years)
- Use in the pediatric patient: Safety and efficacy established in pediatric patients with asthma 6 months to 14 years of age
Interaction
- No clinically important effects on the pharmacokinetics of several drugs
- Used concomitantly with a wide range of commonly prescribed drugs without evidence of clinical adverse interactions
Contraindications
- Montelukast is contraindicated in patients who are hypersensitive to any component of this product
Side Effects
- Common: Diarrhoea, fever, gastrointestinal discomfort, headache, nausea, vomiting, skin reactions, upper respiratory tract infection
- Uncommon: Akathisia, anxiety, arthralgia, asthenia, abnormal behavior, depression, dizziness, drowsiness
- Rare: Angioedema, concentration impaired, disorientation, hepatic disorders, memory loss, palpitations, suicidal tendencies, tremor
Pregnancy & Lactation
- Crosses the placenta following oral dosing in rats and rabbits
- Caution should be exercised when given to a nursing mother
Precautions & Warnings
- Not indicated for use in the reversal of bronchospasm in acute asthma attacks
- Therapy can be continued during acute exacerbations of asthma
- Should not be used as monotherapy for the treatment and management of exercise induced bronchospasm
Overdose Effects
- Usual supportive measures should be employed in the event of overdose
- No adverse experiences in the majority of overdosage reports
Therapeutic Class
Leukotriene receptor antagonists
Storage Conditions
Store in cool & dry place below 30°C, protect from light & moisture
Chemical Structure
- Molecular Formula: C35H36ClNO3S
- Chemical Structure Image: [Link to image]
Common Questions about Lumona 4 mg/3.5 gm Oral Granules
- Lumona 4 mg/3.5 gm Granules is a selective and orally active leukotriene receptor antagonist
- Used to treat asthma or allergic rhinitis
- Effect can be observed after 1-3 hours of administration
- Effect lasts for an average duration of 24 hours
- May be taken with or without food as prescribed by the doctor
- Use in pregnant women should be avoided unless clearly needed
- General Instructions provided